Overview


According to FutureWise analysis the market for aphakia is expected to reach US$ 4.32 billion by 2031 at a CAGR of 11.40%.

Aphakia denotes the condition in which the eye lacks a lens. The lens, positioned behind the iris and pupil, is crucial in directing light onto the retina, facilitating clear vision. Without this lens, the eye's capacity to focus is compromised, resulting in blurred vision. The primary cause of aphakia is cataract surgery, where a clouded natural lens is removed and often replaced with an intraocular lens (IOL). An IOL might not be implanted in some cases, such as infants and confident older children, leaving them aphakic. Trauma to the eye can also result in the loss or damage of the lens. Additionally, rare congenital disabilities can cause individuals to be born without lenses or with abnormal ones. Aphakia manifests through symptoms such as blurred vision, particularly for close-up tasks, and difficulty adjusting focus between distances. Colour perception may also be affected, and a "jiggly" iris or iridodenesis can occur due to the absence of a lens or IOL's stabilizing effect. 

Diagnosis of aphakia involves a comprehensive eye examination by an ophthalmologist, typically using a slit lamp and bright light. In cases of congenital aphakia in unborn babies, ultrasound may be utilized for detection. Treatment for aphakia generally involves surgery to implant an IOL, which replaces the damaged or absent lens. IOL implantation might be performed in newborns in subsequent surgery to minimize complications. Special contact lenses can provide clear vision in babies unsuitable for immediate IOL replacement. Adults can also opt for aphakic contact lenses or glasses. Prompt treatment for babies and children with aphakia is crucial to prevent the development of amblyopia, a condition where the brain disconnects from the eye, leading to irreversible vision impairment.

FutureWise Market Research has published a report that provides an insightful analysis of Aphakia Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Aphakia Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Johnson and Johnson
  • Ophtec BV
  • Novartis AG
  • Nbausch health
  • ZEISS International
  • Rayner Intraocular lenses Limited
  • Aetna Inc
  • CooperVision
  • Menicon Co Ltd
  • Labtician Ophthalmics Inc
  • Artificial Eye Co
  • Allergan
  • Abbott
  • UltraVision CLPL
  • Alcon Inc
  • Bausch and Lomb Incorporated
  • Essilor Vision Foundation Australia
  • Contamac
  • SynergEyes

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in Aphakia Market:

  • In July 2022, Alcon (SIX/NYSE: ALC), a renowned global leader in eye care, introduced the availability of Intraocular lenses (IOLs) from the Clareon® family in the United States. Alcon is dedicated to enhancing visual experiences for individuals worldwide. The advanced IOL material utilized in Clareon offers exceptional visual outcomes and sustained clarity. When compared to competitor IOLs, the glistening-free material employed in Clareon demonstrates remarkably low levels of haze and subsurface nanoglistenings (SSNGs).

 
Among the drivers, the increasing prevalence of cataracts and related eye disorders, particularly among the aging population, is a significant catalyst for market growth. Technological advancements in intraocular lens (IOL) materials and surgical techniques and improved patient outcomes stimulate market expansion. Additionally, rising awareness about available treatments, especially in developed regions, enhances patient engagement and demand for aphakia solutions. The trend towards minimally invasive surgical procedures further drives market growth, offering quicker recovery times and reduced postoperative complications.

However, the market faces restraints that impact its trajectory. Economic limitations in certain regions can hinder patient affordability for advanced treatments, restraining market growth potential. Regulatory complexities and approval processes for new IOLs can also pose challenges, delaying their introduction to the market. In regions with limited access to healthcare services, inadequate awareness about aphakia treatment options might hinder market growth. Moreover, post-surgery complications, although rare, can impact patient outcomes and deter some individuals from seeking treatment.

By Type

  • Primary
  • Secondary

By Cause

  • Congenital Aphakia
  • Surgical Aphakia
  • Acquired Aphakia

By Treatment

  • Spectacles
  • Contact Lenses
  • Intraocular lenses implantation
  • Refractive Surgery
  • Others

By End User

  • Hospitals
  • Opthalmic Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In the Aphakia Market North America occupies a prominent position, driven by advanced healthcare infrastructure, heightened awareness, and availability of advanced treatments. The presence of key market players and significant investments in research and development contribute to North America's market dominance. In Europe, a growing focus on innovative medical technologies and an increasing geriatric population support the expansion of the aphakia market. The Asia Pacific showcases substantial growth potential due to a rising patient population, improving healthcare access, and increasing healthcare expenditure. Developing economies within this region are witnessing a surge in cataract surgeries, driving the demand for aphakia treatments.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Aphakia Market By Cause, By Type, By Treatment, By End Use and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aphakia Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aphakia Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aphakia Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aphakia Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Primary
        2. Secondary

  • 8.   Aphakia Market, By Cause Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Congenital Aphakia
        2. Surgical Aphakia
        3. Acquired Aphakia

  • 9.   Aphakia Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Spectacles
        2. Contact Lenses
        3. Intraocular lenses implantation
        4. Refractive Surgery
        5. Others

  • 10.   Aphakia Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Opthalmic Clinics
        3. Others

  • 11.   North America Aphakia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Aphakia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Aphakia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Aphakia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Aphakia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Johnson and Johnson
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Ophtec BV
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Novartis AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Nbausch health
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. ZEISS International
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Rayner Intraocular lenses Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Aetna Inc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. CooperVision
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Menicon Co Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Labtician Ophthalmics Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Artificial Eye Co
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Allergan
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
            13. Abbott
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. UltraVision CLPL
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Alcon Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Bausch & Lomb Incorporated
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Essilor Vision Foundation Australia
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Contamac
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. SynergEyes
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients